Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
N/A
EC/CAS
236-675-5
Name of the chemical
Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
238-877-9
Name of the chemical
Talc: Hydrated magnesium silicate
Concentration
N/A
EC/CAS
200-559-2
Name of the chemical
Lactose C12H22O11
Concentration
N/A
General Information
Revision date
2007-02-21
Product name
Flagyl(R) ER
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: Blue Tablets
Signal word
WARNING
Hazard statements
Suspected of damaging the unborn child. Suspected of causing cancer.
Additional information
Short Term: The active ingredient is not acutely toxic. Not an eye irritant (based on components) . Long Term: Animal studies indicate that this material may cause adverse effects on the the developing fetus. Known Clinical Effects: Clinical use of this drug has caused nausea, dizziness and effects on blood forming organs. EU Indication of danger: Harmful EU Hazard Symbols: EU Risk Phrases: R40 - Limited evidence of a carcinogenic effect R63 - Possible risk of harm to the unborn child. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.